StockTipsArenaBeta

BUY Gujarat Themis Biosyn Limited — Sumeet Bagadia, Choice Broking

BUYGujarat Themis Biosyn Limited
Gujarat Themis Biosyn share price target & all analyst calls

bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Swing (≤2wk))8 Sept 2026via LiveMint Buy-or-Sell (topic)

Entry₹432.75Inferred
Target₹465
Total upside +7.45% (call closed)
Stop loss₹405-6.41% risk
Exit₹4658 Sept 2026, 11:00 am
Target hit+7.45%0.00%upside left
Follow Sumeet Bagadia for new calls(29% target hit, 413 closed calls)Get alertsWatch GUJTHEM for new buy/sell callsGet alertsSee 151 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 8 Sept 2026
3 supporting1 neutral0 opposing
Supports the BUY call (3)

Gujarat Themis Biosyn Limited's board approved the issuance of up to 82,10,786 equity shares at Rs. 408 per share via preferential issue, aggregating Rs. 335 crore. This is subject to necessary approv

NSE · Outcome of Board Meeting·1 Sept · 6d ago

(opens in new tab)

40% Jump In Six Months: Gujarat Themis Biosyn Share Price Rises Over 4% In Trade. Here's Why

NewsNdtv-Profit·31 Aug · 1w ago

(opens in new tab)

Gujarat Themis Biosyn gains 6% after QIP approval; Q1 profit rises 22%

NewsCnbc-Tv18·26 Aug · 2w ago

(opens in new tab)
Neutral / worth noting (1)

Gujarat Themis Biosyn Ltd's Board of Directors approved the preliminary placement document and authorized the opening of a Qualified Institutions Placement (QIP) of equity shares. The floor price for

BSE · Others·25 Aug · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

More from Sumeet Bagadia, Choice Broking

Every call and its outcome